Breakthrough Therapy for Novartis – Analyst Blog
Novartis ( NVS ) recently received Breakthrough Therapy Designation from the U.S. Food and Drug Administration (FDA) for pipeline candidate …read more
Novartis ( NVS ) recently received Breakthrough Therapy Designation from the U.S. Food and Drug Administration (FDA) for pipeline candidate …read more
Bill Nygren released his Oakmark Fund second quarter portfolio earlier today which reported a total of 53 stocks valued at …read more
Agilent Technologies’ ( A ) fiscal third quarter earnings per share of 68 cents beat the Zacks Consensus Estimate by …read more
Leading U.S. Communication firm, AT&T Inc. ( T ) has announced the launch of two new smartphones, which will run …read more
One of the biggest problems faced by the new investor, or those attempting to control their own portfolio for the …read more
Reuters reported that last week the acquisition of the financial services corporation, NYSE Euronext Inc . ( NYX ) by …read more
Johnson & Johnson ( JNJ ) recently completed its previously announced acquisition of privately held, pharmaceutical discovery and development company …read more
Peregrine Pharmaceuticals ( PPHM ) recently presented encouraging data related to immune stimulatory mechanism of action of phosphatidylserine (PS) targeting …read more
American Water Works Company ‘s ( AWK ) unit Iowa American Water has started to drill a well and also …read more
Last week, Apple ( AAPL ) investors rejoiced in the hope that billionaire investor Icahn’s demands would be met while …read more